Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Median PS Value is $58.86 as of Jul. 13, 2026, which is 6096% above its 10-year median of 0.95. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 262 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks better than 56.49% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for COSMOS Pharmaceutical's Median PS Value or its related term are showing as below:
CSMYF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.63 Med: 0.95 Max: 1.43
Current: 0.63
During the past 13 years, the highest Price to Median PS Value of COSMOS Pharmaceutical was 1.43. The lowest was 0.63. And the median was 0.95.
CSMYF's Price-to-Median-PS-Value is ranked better than 56.49% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs CSMYF: 0.63
COSMOS Pharmaceutical (OTCPK:CSMYF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
COSMOS Pharmaceutical's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
37.06
/
58.86
=
0.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Median PS Value Related Terms
COSMOS Pharmaceutical Median PS Value Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Median PS Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.653.
COSMOS Pharmaceutical's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $90.136.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (CSMYF) has a Median PS Value of $58.86 as of Jul. 13, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on COSMOS Pharmaceutical and its competitors. This is 6096% above median its historical median of 0.95. Over the past decade, COSMOS Pharmaceutical's Median PS Value has ranged from 0.63 to 1.43. According to the industry distribution chart, COSMOS Pharmaceutical ranks #114 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 43.5%.
Is COSMOS Pharmaceutical's Median PS Value too high?
COSMOS Pharmaceutical's current Median PS Value of $58.86 is 6096% above median its 10-year median of 0.95. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 1.43. The Healthcare Providers & Services industry median Median PS Value is 0.71. COSMOS Pharmaceutical's value of $58.86 is 8190.1% above this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #114 out of 262 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Median PS Value compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #114 out of 262 companies for Median PS Value. This puts COSMOS Pharmaceutical in the upper half of its industry. The industry median Median PS Value is 0.71. COSMOS Pharmaceutical's value of $58.86 is 8190.1% above this benchmark. Historically, COSMOS Pharmaceutical's own Median PS Value has ranged from 0.63 to 1.43 over the past decade. While the company's 10-year median is 0.95 vs. the industry median of 0.71, COSMOS Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Median PS Value of $58.86 is 8190.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Median PS Value is $58.86, which is 6096% above median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Median PS Value is $58.86, which is 6096% above median its 10-year median of 0.95 and 8190.1% above the Healthcare Providers & Services industry median of 0.71. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Median PS Value is $58.86 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Median PS Value: $58.86 (6096% above median its 10-year median of 0.95)
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 8190.1% above the Healthcare Providers & Services median (#114 of 262)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
